Official Order for Stage 2 and Stage 3 of the Review of cost effectiveness of Type 2 Diabetes medicines

Clinical and cost utility evaluation of glucagon-like peptide 1 analogues for the treatment of type 2 diabetes in the Australian setting

An Tran-Duy, Tessa Peasgood, Patrick Abraham, Philip Clarke

2021-12-14

Clinical and cost-utility evaluation of sodium-glucose co-transporter 2 inhibitors for the treatment of type 2 diabetes in the Australian setting

An Tran-Duy, Andrew Palmer, Philip Clarke

2021-11-26